Use of signal detection methods to identify associations between prenatal medication exposure and subsequent childhood cancers: a Nordic hypothesis-generating registry-based study
The IC may be the most appropriate method for identifying signals within this type of data. Reported signals should not be considered sufficient evidence of causal association and must be followed-up by tailored investigations that consider confounding by indication.
Authors
- Harold Johnson (ORCID: https://orcid.org/0000-0002-3055-769X)
- Sarah Hjorth (ORCID: https://orcid.org/0000-0003-2841-5868)
- Joan K. Morris (ORCID: https://orcid.org/0000-0002-7164-612X)
- Ulrika Nörby (ORCID: https://orcid.org/0000-0003-0396-5986)
- Maarit K. Leinonen (ORCID: https://orcid.org/0000-0002-7631-4749)
- Anton Pottegård (ORCID: https://orcid.org/0000-0001-9314-5679)
- Hedvig Nordeng (ORCID: https://orcid.org/0000-0001-6361-2918)
Institutions
- St George's, University of London (GB)
- University of Southern Denmark (DK)
- University of Oslo (NO)
- Finnish Institute for Health and Welfare (FI)
- Stockholm Health Care Services (SE)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1080/14740338.2025.2461204
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Helsingin Yliopisto
- Universitetet i Oslo
- Medical Research Council